Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child

[1]  T. Ohta.  [Histiocytic sarcoma]. , 2020, Ryoikibetsu shokogun shirizu.

[2]  Y. Tsunematsu,et al.  Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study , 2016, International Journal of Hematology.

[3]  M. V. van Noesel,et al.  Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. , 2015, Blood.

[4]  Sarah G. Boles,et al.  Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation , 2015, Case reports in hematology.

[5]  D. Wechsler,et al.  Successful treatment of pediatric histiocytic sarcoma using abbreviated high‐risk leukemia chemotherapy , 2014, Pediatric blood & cancer.

[6]  J. Teruya-Feldstein,et al.  Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab , 2012, Cancer.

[7]  E. Ritchie,et al.  Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Abidi,et al.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant , 2007, American journal of hematology.

[9]  J. Bogart,et al.  Histiocytic Sarcoma in a 3-Year-Old Male: A Case Report , 2005, Pediatrics.

[10]  Tudung T Nguyen,et al.  Expression of CD163 (Hemoglobin Scavenger Receptor) in Normal Tissues, Lymphomas, Carcinomas, and Sarcomas Is Largely Restricted to the Monocyte/Macrophage Lineage , 2005, The American journal of surgical pathology.

[11]  M. Miettinen,et al.  Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163 , 2005, Modern Pathology.

[12]  E. Jaffe,et al.  Extranodal Histiocytic Sarcoma: Clinicopathologic Analysis of 14 Cases of a Rare Epithelioid Malignancy , 2004, The American journal of surgical pathology.

[13]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[14]  C. D. Wu,et al.  Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. , 2003, Journal of pediatric hematology/oncology.

[15]  R. Warnke,et al.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases , 2002, Histopathology.

[16]  G. Peters,et al.  Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs. , 1998, European journal of cancer.

[17]  A. Saven,et al.  2-Chlorodeoxyadenosine-Induced Complete Remissions in Langerhans-Cell Histiocytosis , 1994, Annals of Internal Medicine.

[18]  D. Carson,et al.  Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. , 1990, The Journal of clinical investigation.

[19]  A. Yu,et al.  Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes , 1983 .

[20]  Shigeo Nakamura,et al.  Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. , 2013, Journal of clinical and experimental hematopathology : JCEH.

[21]  E. Estey,et al.  Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions. , 1996, Blood.